CIK 0000882796 · Large accelerated filer
BIOCRYST PHARMACEUTICALS INC
Sign in to watch- Ticker
- BCRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 621413174
- Phone
- 919-859-1302
- Business address
- 4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
- 8-K Event Material agreement · Regulation FD disclosure
- 8-K Event Other events
- 8-K Event Executive or director change
- 8-K Event Executive or director change
- 8-K Event Results of operations · Regulation FD disclosure
- UPLOAD Other SEC-generated Letter
- 8-K Event Executive or director change
- 10-K/A Report 10-K/A
- 8-K Event Executive or director change
- SC 13G/A Stake Amended Statement of Ownership
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- CT ORDER Other Confidential Order
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 10-Q Report Quarterly Report
- 4 Insider Changes in Ownership
Page 72 of 99 · 1,967 filings